Sg Americas Securities, LLC Opti Nose, Inc. Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$0.82 - $1.44 $11,015 - $19,343	13,433 New	13,433 $14,000
Q4 2023 Jan 12, 2024	BUY	$1.02 - $1.47 $3,379 - $4,870	3,313 Added 24.21%	17,000 $22,000
Q3 2023 Oct 13, 2023	BUY	$0.93 - $1.38 $12,728 - $18,888	13,687 New	13,687 $17,000
Q3 2020 Nov 09, 2020	SELL	$3.69 - $7.09 $67,084 - $128,896	-18,180 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$3.58 - $7.44 $65,084 - $135,259	18,180 New	18,180 $135,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $45M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.